Activating mutations in EGFR and PI3K promote ATF4 induction for NSCLC cell survival during amino acid deprivation.

Takahashi, Mizuki; Okamoto, Yuka; Kato, Yu; Shirahama, Hitomi; Tsukahara, Satomi; Sugimoto, Yoshikazu; Tomida, Akihiro.

Afiliación

Takahashi M; Genome Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Okamoto Y; Division of Chemotherapy, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.
Kato Y; Genome Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Shirahama H; Division of Chemotherapy, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.
Tsukahara S; Genome Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Sugimoto Y; Genome Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Tomida A; Division of Chemotherapy, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.

Heliyon ; 9(4): e14799, 2023 Apr.

Article en En | MEDLINE | ID: mdl-37025861